D-Index & Metrics Best Publications
Microbiology
France
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 90 Citations 39,123 343 World Ranking 168 National Ranking 10
Medicine D-index 109 Citations 49,821 508 World Ranking 2529 National Ranking 63

Research.com Recognitions

Awards & Achievements

2022 - Research.com Microbiology in France Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Disease

His primary areas of study are Internal medicine, Immunology, Mycosis, Surgery and Transplantation. His Internal medicine research includes elements of Gastroenterology and Amphotericin B, Voriconazole, Caspofungin. His Immunology research is multidisciplinary, incorporating elements of Epidemiology and Incidence.

His Mycosis research includes themes of Fluconazole, Intensive care, Intensive care medicine, Disease and Immune reconstitution inflammatory syndrome. His Surgery study integrates concerns from other disciplines, such as Diabetes mellitus and Cancer. Olivier Lortholary has researched Transplantation in several fields, including Immunosuppression, Aspergillosis and Zygomycosis.

His most cited work include:

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (3691 citations)
  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis (2622 citations)
  • Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. (1551 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Immunology, Internal medicine, Surgery, Cryptococcosis and Intensive care medicine. The Immunology study combines topics in areas such as Immune reconstitution inflammatory syndrome, Acquired immunodeficiency syndrome and Disease. The various areas that Olivier Lortholary examines in his Internal medicine study include Gastroenterology and Aspergillosis.

Olivier Lortholary works in the field of Surgery, namely Mucormycosis. His research integrates issues of Flucytosine, Amphotericin B, Fluconazole, Cryptococcus neoformans and Mycosis in his study of Cryptococcosis. His research investigates the link between Intensive care medicine and topics such as Epidemiology that cross with problems in Incidence.

He most often published in these fields:

  • Immunology (45.98%)
  • Internal medicine (44.66%)
  • Surgery (22.33%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (44.66%)
  • Aspergillosis (19.21%)
  • Intensive care medicine (22.00%)

In recent papers he was focusing on the following fields of study:

Olivier Lortholary mostly deals with Internal medicine, Aspergillosis, Intensive care medicine, Immunology and Fluconazole. He has included themes like Meningitis and Gastroenterology in his Internal medicine study. Olivier Lortholary combines subjects such as Mucormycosis, Clinical trial and Cryptococcosis with his study of Intensive care medicine.

His research in Immunology intersects with topics in Immune reconstitution inflammatory syndrome, Acquired immunodeficiency syndrome and Aspergillus. His Fluconazole research is multidisciplinary, relying on both Amphotericin B, Fungemia and Intensive care. His Transplantation research integrates issues from Disease, Posaconazole and Terbinafine.

Between 2017 and 2021, his most popular works were:

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)
  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
  • Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa (129 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

His primary areas of investigation include Internal medicine, Prospective cohort study, Intensive care medicine, Fluconazole and Aspergillosis. His Internal medicine research is multidisciplinary, incorporating perspectives in Opportunistic infection and Echinocandin. His work deals with themes such as Mucormycosis and Computed tomography, which intersect with Intensive care medicine.

His studies deal with areas such as Meningitis, Incidence, Antiretroviral naive, Young adult and Meta-analysis as well as Fluconazole. His Aspergillosis study combines topics in areas such as Voriconazole and Caspofungin. His study looks at the relationship between Caspofungin and fields such as Drug, as well as how they intersect with chemical problems.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)

3691 Citations

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett.
The New England Journal of Medicine (2002)

3478 Citations

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

John R. Perfect;William E. Dismukes;Francoise Dromer;David L. Goldman.
Clinical Infectious Diseases (2010)

2363 Citations

Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.

Loïc Guillevin;François Lhote;Martine Gayraud;Pascal Cohen.
Medicine (1996)

1160 Citations

Epidemiology and Clinical Manifestations of Mucormycosis

George Petrikkos;Anna Skiada;Olivier Lortholary;Emmanuel Roilides.
Clinical Infectious Diseases (2012)

869 Citations

Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

Oliver A. Cornely;Johan Maertens;Mark Bresnik;Ramin Ebrahimi.
Clinical Infectious Diseases (2007)

720 Citations

Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign

Reginald E. Greene;Haran T. Schlamm;Jörg W. Oestmann;Paul Stark.
Clinical Infectious Diseases (2007)

668 Citations

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

Olivier Leroy;Jean-Pierre Gangneux;Philippe Montravers;Jean-Paul Mira.
Critical Care Medicine (2009)

640 Citations

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)

563 Citations

Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells

Ludovic de Beaucoudrey;Ludovic de Beaucoudrey;Anne Puel;Anne Puel;Orchidée Filipe-Santos;Orchidée Filipe-Santos;Aurélie Cobat;Aurélie Cobat.
Journal of Experimental Medicine (2008)

555 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Olivier Lortholary

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 192

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 168

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 163

David W. Denning

David W. Denning

University of Manchester

Publications: 160

Loïc Guillevin

Loïc Guillevin

Université Paris Cité

Publications: 147

Jean-Laurent Casanova

Jean-Laurent Casanova

Rockefeller University

Publications: 144

Anne Puel

Anne Puel

Rockefeller University

Publications: 135

John R. Perfect

John R. Perfect

Duke University

Publications: 124

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 122

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 121

Laurent Abel

Laurent Abel

Inserm : Institut national de la santé et de la recherche médicale

Publications: 120

Monica A. Slavin

Monica A. Slavin

Peter MacCallum Cancer Centre

Publications: 118

Stéphane Bretagne

Stéphane Bretagne

Université Paris Cité

Publications: 115

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 113

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 107

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 106

Something went wrong. Please try again later.